Beyond Glycemic Management: Optimizing Cardiovascular and Renal Outcomes in People with Type 2 Diabetes (Unaccredited)

CAN-eng

$0

gratuit

Non accrédité

30 min

Diabetes, Medication Management

0.5 Credits

Description du cours

Optimal management of people with type 2 diabetes has increased in complexity over the last several years. The focus is not only on the management of hyperglycemia, but also on interventions that have been associated with a reduction in the development and progression of complications such as cardiovascular disease and chronic kidney disease. This program is focused on providing clinicians with a quick update on the optimal management of individuals with type 2 diabetes with chronic kidney disease or at high-risk of cardiovascular disease. This case-based practical program will provide healthcare professionals with a quick update on these topics to allow them to apply evidence-informed care in practice.

Détails du cours

Date d'expiration : 2026-11-07

Métiers: Médecin

Faculté

  • Ronald Goldenberg, MD, FRCPC, FACE
  • Robert Hauptman, BMSc, MD, MCFP
  • Sofia Nastis, BMSc, MD, CCFP
  • Jahan Lakhani, MD, CCFP
  • Bilal Hatoum, BSc Pharm, RPh, APA, CDE
  • Susie Jin, RPh, CDE, CRE

Accréditation

Objectif(s) d'apprentissage

Upon successful completion of this continuing education activity, you will be better able to:

  • Analyze the components of the ABCDESSS approach in managing individuals with type 2 diabetes at high risk for cardiovascular disease
  • Create treatment plans for adults with type 2 diabetes and chronic kidney disease or cardiovascular risk factors, integrating pharmacological interventions, lifestyle modifications, and regular monitoring strategies
  • Evaluate the appropriateness of using SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists in adults with type 2 diabetes and chronic kidney disease, based on current evidence and guideline recommendations
  • Apply evidence-based strategies to adjust antihyperglycemic agents and manage potential side effects in people with type 2 diabetes and varying levels of renal function